这是一篇来自已证抗体库的有关人类 eNOS的综述,是根据105篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合eNOS 抗体。
eNOS 同义词: ECNOS; eNOS

艾博抗(上海)贸易有限公司
小鼠 单克隆(M221)
  • 免疫印迹; 小鼠; 1:1000; 图 4b
艾博抗(上海)贸易有限公司 eNOS抗体(Abcam, ab76198)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4b). BMC Med (2022) ncbi
小鼠 单克隆(M221)
  • 免疫组化-石蜡切片; 大鼠; 1:50; 图 7
艾博抗(上海)贸易有限公司 eNOS抗体(Abcam, ab76198)被用于被用于免疫组化-石蜡切片在大鼠样本上浓度为1:50 (图 7). Biol Sex Differ (2021) ncbi
小鼠 单克隆(M221)
  • 免疫组化-石蜡切片; 小鼠; 1:300; 图 6c
艾博抗(上海)贸易有限公司 eNOS抗体(Abcam, ab76198)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:300 (图 6c). Front Cell Dev Biol (2021) ncbi
小鼠 单克隆(M221)
  • 免疫印迹基因敲除验证; 小鼠; 图 5c
  • 免疫组化; 小鼠; 1:500; 图 5a
艾博抗(上海)贸易有限公司 eNOS抗体(Abcam, ab76198)被用于被用于免疫印迹基因敲除验证在小鼠样本上 (图 5c) 和 被用于免疫组化在小鼠样本上浓度为1:500 (图 5a). Mol Med Rep (2020) ncbi
小鼠 单克隆(M221)
  • 免疫印迹; 人类; 1:1000; 图 3d
艾博抗(上海)贸易有限公司 eNOS抗体(Abcam, AB76198)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3d). Nat Commun (2020) ncbi
小鼠 单克隆(M221)
  • 免疫印迹; 小鼠; 1:100; 图 7a
艾博抗(上海)贸易有限公司 eNOS抗体(Abcam, ab76198)被用于被用于免疫印迹在小鼠样本上浓度为1:100 (图 7a). elife (2020) ncbi
小鼠 单克隆(M221)
  • 免疫印迹; 大鼠; 1:1000; 图 5a
艾博抗(上海)贸易有限公司 eNOS抗体(Abcam, ab76198)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 5a). Aging (Albany NY) (2020) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 3d, 8b
艾博抗(上海)贸易有限公司 eNOS抗体(Abcam, ab5589)被用于被用于免疫印迹在小鼠样本上 (图 3d, 8b). Pharmacol Res (2020) ncbi
小鼠 单克隆(M221)
  • 免疫印迹; 小鼠; 1:1000; 图 2g, j
艾博抗(上海)贸易有限公司 eNOS抗体(Abcam, ab76198)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 2g, j). CNS Neurosci Ther (2020) ncbi
小鼠 单克隆(M221)
  • 免疫印迹; 人类; 1:1000; 图 5a
  • 免疫印迹; 大鼠; 1:1000; 图 4a
  • 免疫印迹; 小鼠; 1:1000; 图 3a
艾博抗(上海)贸易有限公司 eNOS抗体(Abcam, ab76198)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5a), 被用于免疫印迹在大鼠样本上浓度为1:1000 (图 4a) 和 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 3a). Biosci Rep (2019) ncbi
小鼠 单克隆(M221)
  • 免疫印迹; 人类; 1:500; 图 2c
艾博抗(上海)贸易有限公司 eNOS抗体(Abcam, ab76198)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 2c). Int J Mol Med (2019) ncbi
单克隆
  • 免疫印迹; 人类; 图 s4l
艾博抗(上海)贸易有限公司 eNOS抗体(Abcam, ab76199)被用于被用于免疫印迹在人类样本上 (图 s4l). Mol Cell (2017) ncbi
小鼠 单克隆(M221)
  • 免疫印迹; 人类; 1:4000; 图 7b
艾博抗(上海)贸易有限公司 eNOS抗体(Abcam, ab76198)被用于被用于免疫印迹在人类样本上浓度为1:4000 (图 7b). Sci Rep (2016) ncbi
小鼠 单克隆(M221)
  • 免疫印迹; 人类; 1:1000; 图 7
艾博抗(上海)贸易有限公司 eNOS抗体(Abcam, ab76198)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 7). Oncotarget (2016) ncbi
单克隆
  • 免疫印迹; 人类; 1:500; 图 7
艾博抗(上海)贸易有限公司 eNOS抗体(Abcam, ab76199)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 7). Oncotarget (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 大鼠; 1:100; 图 3
艾博抗(上海)贸易有限公司 eNOS抗体(Abcam, 5589)被用于被用于免疫组化-石蜡切片在大鼠样本上浓度为1:100 (图 3). Sci Rep (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 犬; 1:500; 图 s1a
艾博抗(上海)贸易有限公司 eNOS抗体(Abcam, ab5589)被用于被用于免疫印迹在犬样本上浓度为1:500 (图 s1a). J Am Heart Assoc (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化; pigs ; 图 9
艾博抗(上海)贸易有限公司 eNOS抗体(Abcam, ab5589)被用于被用于免疫组化在pigs 样本上 (图 9). J Am Heart Assoc (2016) ncbi
单克隆
  • 免疫印迹; 大鼠
艾博抗(上海)贸易有限公司 eNOS抗体(Abcam, ab76199)被用于被用于免疫印迹在大鼠样本上. Toxicol Pathol (2014) ncbi
圣克鲁斯生物技术
小鼠 单克隆(A-9)
  • 免疫印迹; 大鼠; 图 2a
圣克鲁斯生物技术 eNOS抗体(Santa Cruz, sc-376751)被用于被用于免疫印迹在大鼠样本上 (图 2a). Oxid Med Cell Longev (2021) ncbi
小鼠 单克隆(A-9)
  • 免疫印迹; 人类; 图 4
圣克鲁斯生物技术 eNOS抗体(Santa Cruz Biotechnology, A-9)被用于被用于免疫印迹在人类样本上 (图 4). PLoS Genet (2016) ncbi
小鼠 单克隆(pT495.33)
  • 免疫印迹; 大鼠; 1:1000
圣克鲁斯生物技术 eNOS抗体(Santa Cruz, sc-136519)被用于被用于免疫印迹在大鼠样本上浓度为1:1000. Free Radic Biol Med (2014) ncbi
小鼠 单克隆(B-5)
  • 免疫印迹; 小鼠; 1:500
圣克鲁斯生物技术 eNOS抗体(Santa Cruz Biotechnology, sc-136977)被用于被用于免疫印迹在小鼠样本上浓度为1:500. Clin Exp Pharmacol Physiol (2014) ncbi
小鼠 单克隆(A-9)
  • 免疫印迹; 大鼠; 1:1000
圣克鲁斯生物技术 eNOS抗体(Santa Cruz Biotech, sc-376751)被用于被用于免疫印迹在大鼠样本上浓度为1:1000. PLoS ONE (2013) ncbi
赛默飞世尔
domestic rabbit 多克隆
  • 免疫组化-冰冻切片; 大鼠; 1:100; 图 6a
赛默飞世尔 eNOS抗体(Invitrogen, PA1-037)被用于被用于免疫组化-冰冻切片在大鼠样本上浓度为1:100 (图 6a). Front Pharmacol (2022) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:400; 图 s3a
赛默飞世尔 eNOS抗体(Invitrogen, PA3-031A)被用于被用于免疫印迹在小鼠样本上浓度为1:400 (图 s3a). Nitric Oxide (2018) ncbi
小鼠 单克隆(6H2)
  • 免疫细胞化学; 人类; 图 5h
赛默飞世尔 eNOS抗体(Pierce, MA5-15559)被用于被用于免疫细胞化学在人类样本上 (图 5h). Acta Histochem (2017) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 大鼠; 图 3
赛默飞世尔 eNOS抗体(Invitrogen, RB-9279-P)被用于被用于免疫组化-石蜡切片在大鼠样本上 (图 3). Exp Eye Res (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 大鼠; 1:250; 图 2
赛默飞世尔 eNOS抗体(Pierce, PA3-031A)被用于被用于免疫组化-石蜡切片在大鼠样本上浓度为1:250 (图 2). Ren Fail (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化; 大鼠; 1:250; 图 2
  • 免疫印迹; 大鼠; 1:1000; 图 3
赛默飞世尔 eNOS抗体(Pierce antibody product, PA3-031A)被用于被用于免疫组化在大鼠样本上浓度为1:250 (图 2) 和 被用于免疫印迹在大鼠样本上浓度为1:1000 (图 3). Syst Biol Reprod Med (2016) ncbi
domestic rabbit 多克隆
赛默飞世尔 eNOS抗体(Thermo Scientific, PA1-037)被用于. J Biomech (2015) ncbi
赛信通(上海)生物试剂有限公司
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 1s4a
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9571)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 1s4a). elife (2022) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 2g
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling Technology, 9571)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 2g). Arterioscler Thromb Vasc Biol (2021) ncbi
domestic rabbit 多克隆
  • 免疫细胞化学; 人类; 1:200; 图 5j
  • 免疫印迹; 人类; 1:1000; 图 2a
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9571)被用于被用于免疫细胞化学在人类样本上浓度为1:200 (图 5j) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 2a). elife (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 牛; 图 s3a
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9571)被用于被用于免疫印迹在牛样本上 (图 s3a). JCI Insight (2020) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:100; 图 7a
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell signaling Technology, 9571)被用于被用于免疫印迹在小鼠样本上浓度为1:100 (图 7a). elife (2020) ncbi
domestic rabbit 单克隆(C9C3)
  • 免疫印迹; 家羊; 1:1000; 图 s10a
赛信通(上海)生物试剂有限公司 eNOS抗体(Santa Cruz Biotechnology, 9570)被用于被用于免疫印迹在家羊样本上浓度为1:1000 (图 s10a). Int J Mol Sci (2020) ncbi
domestic rabbit 单克隆(C9C3)
  • 免疫印迹; 小鼠; 图 3d, 8b
赛信通(上海)生物试剂有限公司 eNOS抗体(cell signalling technology, 9570)被用于被用于免疫印迹在小鼠样本上 (图 3d, 8b). Pharmacol Res (2020) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 3f
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9571)被用于被用于免疫印迹在人类样本上 (图 3f). Sci Adv (2020) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:500; 图 s9a
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9572S)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 s9a). Sci Rep (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:500; 图 s9a
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9571S)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 s9a). Sci Rep (2019) ncbi
domestic rabbit 单克隆(C9C3)
  • 免疫印迹; 人类; 1:500; 图 3a
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9570)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 3a). Exp Ther Med (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 牛; 图 1a
  • 免疫组化; 小鼠; 1:100; 图 3e
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9571)被用于被用于免疫印迹在牛样本上 (图 1a) 和 被用于免疫组化在小鼠样本上浓度为1:100 (图 3e). J Clin Invest (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 5a
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9571S)被用于被用于免疫印迹在人类样本上 (图 5a). Cell Rep (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 e7e
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9572)被用于被用于免疫印迹在小鼠样本上 (图 e7e). Nature (2019) ncbi
domestic rabbit 单克隆(C9C3)
  • 免疫印迹; 小鼠; 图 4a
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9570)被用于被用于免疫印迹在小鼠样本上 (图 4a). Biomed Res Int (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 2b
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9572)被用于被用于免疫印迹在小鼠样本上 (图 2b). Cell (2018) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 2b
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9571)被用于被用于免疫印迹在小鼠样本上 (图 2b). Sci Transl Med (2017) ncbi
domestic rabbit 单克隆(C9C3)
  • 免疫印迹; 人类; 图 9e
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9570)被用于被用于免疫印迹在人类样本上 (图 9e). J Clin Invest (2017) ncbi
小鼠 单克隆(6H2)
  • 免疫印迹; 人类; 图 9e
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 5880)被用于被用于免疫印迹在人类样本上 (图 9e). J Clin Invest (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 2a
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9572)被用于被用于免疫印迹在人类样本上 (图 2a). Int J Radiat Biol (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 2a
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9571)被用于被用于免疫印迹在人类样本上 (图 2a). Int J Radiat Biol (2017) ncbi
domestic rabbit 单克隆(C9C3)
  • 免疫印迹; 人类; 图 5m, s4l
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9570)被用于被用于免疫印迹在人类样本上 (图 5m, s4l). Mol Cell (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 3b
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9572)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3b). FASEB J (2017) ncbi
domestic rabbit 单克隆(C9C3)
  • 免疫印迹; 人类; 1:1000; 图 3b
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9570)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3b). FASEB J (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 大鼠; 1:500; 图 7d
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9571)被用于被用于免疫印迹在大鼠样本上浓度为1:500 (图 7d). J Vasc Res (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 8I
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9572)被用于被用于免疫印迹在人类样本上 (图 8I). Autophagy (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 s7h
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9571)被用于被用于免疫印迹在人类样本上 (图 s7h). J Clin Invest (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 s7h
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9572)被用于被用于免疫印迹在人类样本上 (图 s7h). J Clin Invest (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 1b
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9571)被用于被用于免疫印迹在人类样本上 (图 1b). J Clin Invest (2016) ncbi
domestic rabbit 单克隆(C9C3)
  • 免疫印迹; 人类; 图 5b
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling Technology, 9570S)被用于被用于免疫印迹在人类样本上 (图 5b). Physiol Rep (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 5d
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell signaling, 9571)被用于被用于免疫印迹在人类样本上 (图 5d). Am J Physiol Heart Circ Physiol (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 3c
赛信通(上海)生物试剂有限公司 eNOS抗体(cell signalling, 9572)被用于被用于免疫印迹在人类样本上 (图 3c). J Cereb Blood Flow Metab (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 s6d
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9571)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 s6d). Nature (2016) ncbi
domestic rabbit 单克隆(C9C3)
  • 免疫细胞化学; 小鼠; 图 2b
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell signaling, 9570)被用于被用于免疫细胞化学在小鼠样本上 (图 2b). Cell Res (2016) ncbi
domestic rabbit 单克隆(49G3)
  • 免疫印迹; 人类; 图 s1
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling Tech, 9586)被用于被用于免疫印迹在人类样本上 (图 s1). Sci Rep (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 3d
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9571)被用于被用于免疫印迹在人类样本上 (图 3d). Sci Rep (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 3d
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9574)被用于被用于免疫印迹在人类样本上 (图 3d). Sci Rep (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:2000; 图 3
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling Technology, 9572)被用于被用于免疫印迹在小鼠样本上浓度为1:2000 (图 3). Oxid Med Cell Longev (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 3
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling Technology, 9574)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 3). Oxid Med Cell Longev (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 3
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling Technology, 9571)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 3). Oxid Med Cell Longev (2016) ncbi
domestic rabbit 单克隆(C9C3)
  • 免疫组化-石蜡切片; 小鼠; 1:100; 图 3
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9570)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:100 (图 3). J Clin Invest (2016) ncbi
domestic rabbit 单克隆(C9C3)
  • 免疫印迹; pigs ; 图 10
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell signaling, 9570)被用于被用于免疫印迹在pigs 样本上 (图 10). J Biol Chem (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; pigs ; 图 10
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell signaling, 9574)被用于被用于免疫印迹在pigs 样本上 (图 10). J Biol Chem (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化-冰冻切片; 小鼠; 1:100; 图 6e
  • 免疫印迹; 小鼠; 1:1000; 图 6f
  • 免疫印迹; 人类; 1:1000; 图 5b
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9571)被用于被用于免疫组化-冰冻切片在小鼠样本上浓度为1:100 (图 6e), 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 6f) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 5b). Oncotarget (2016) ncbi
domestic rabbit 单克隆(49G3)
  • 免疫印迹; 小鼠; 图 5
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling Technology, 9586)被用于被用于免疫印迹在小鼠样本上 (图 5). Biochim Biophys Acta (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 5
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling Technology, 9571)被用于被用于免疫印迹在小鼠样本上 (图 5). Biochim Biophys Acta (2016) ncbi
domestic rabbit 单克隆(C9C3)
  • 免疫印迹; 人类; 图 3a
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9570)被用于被用于免疫印迹在人类样本上 (图 3a). J Biol Chem (2015) ncbi
domestic rabbit 单克隆(C9C3)
  • 免疫印迹; 人类; 图 5b
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9570)被用于被用于免疫印迹在人类样本上 (图 5b). PLoS ONE (2015) ncbi
domestic rabbit 单克隆(49G3)
  • 免疫印迹; 人类; 图 5b
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9586)被用于被用于免疫印迹在人类样本上 (图 5b). PLoS ONE (2015) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9572)被用于被用于免疫印迹在人类样本上. J Diabetes (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9571)被用于被用于免疫印迹在人类样本上. J Diabetes (2016) ncbi
domestic rabbit 单克隆(C9C3)
  • 免疫印迹; 小鼠; 1:1000; 图 s3
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling Technology, C9C3)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 s3). Nat Commun (2015) ncbi
domestic rabbit 单克隆(49G3)
  • 其他; 人类; 1:100; 图 6
  • 免疫组化-石蜡切片; 人类; 1:100; 图 7c,8b
  • 其他; 小鼠; 1:100; 图 6
  • 免疫组化-石蜡切片; 小鼠; 1:100; 图 4a,4b,4c,4d
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling Technology, 9586)被用于被用于其他在人类样本上浓度为1:100 (图 6), 被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 7c,8b), 被用于其他在小鼠样本上浓度为1:100 (图 6) 和 被用于免疫组化-石蜡切片在小鼠样本上浓度为1:100 (图 4a,4b,4c,4d). Int J Mol Sci (2014) ncbi
domestic rabbit 单克隆(49G3)
  • 免疫印迹; 小鼠; 1:1000; 图 s6
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9586)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 s6). Nat Commun (2014) ncbi
domestic rabbit 单克隆(C9C3)
  • 免疫印迹; 大鼠; 1:1000
赛信通(上海)生物试剂有限公司 eNOS抗体(Cell Signaling, 9570)被用于被用于免疫印迹在大鼠样本上浓度为1:1000. Diabetes Res Clin Pract (2013) ncbi
碧迪BD
小鼠 单克隆(19/eNOS/S1177)
  • 免疫印迹; 小鼠; 1:1000; 图 5f
碧迪BD eNOS抗体(BD Biosciences, 612392)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5f). J Clin Invest (2022) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 小鼠; 1:1000; 图 5f
碧迪BD eNOS抗体(BD Biosciences, 610296)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5f). J Clin Invest (2022) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 小鼠; 1:250; 图 6
碧迪BD eNOS抗体(BD Biosciences, 610297)被用于被用于免疫印迹在小鼠样本上浓度为1:250 (图 6). Aging (Albany NY) (2021) ncbi
小鼠 单克隆(19/eNOS/S1177)
  • 免疫印迹; 小鼠; 图 2b
  • 免疫印迹; 人类; 图 2c
碧迪BD eNOS抗体(BD, 612392)被用于被用于免疫印迹在小鼠样本上 (图 2b) 和 被用于免疫印迹在人类样本上 (图 2c). Biomolecules (2021) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 牛; 图 s3a
碧迪BD eNOS抗体(BD Biosciences, 610296)被用于被用于免疫印迹在牛样本上 (图 s3a). JCI Insight (2020) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 人类; 图 3e
碧迪BD eNOS抗体(BD Biosciences, 610297)被用于被用于免疫印迹在人类样本上 (图 3e). Sci Adv (2020) ncbi
小鼠 单克隆(19/eNOS/S1177)
  • 免疫印迹; 人类; 图 7a
碧迪BD eNOS抗体(BD Biosciences, 612393)被用于被用于免疫印迹在人类样本上 (图 7a). Cell Rep (2019) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫组化; 牛; 1:100; 图 3e
  • 免疫印迹; 牛; 图 1d
碧迪BD eNOS抗体(BD Biosciences, 610296)被用于被用于免疫组化在牛样本上浓度为1:100 (图 3e) 和 被用于免疫印迹在牛样本上 (图 1d). J Clin Invest (2019) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 小鼠; 1:2000; 图 5c
碧迪BD eNOS抗体(BD, 610297)被用于被用于免疫印迹在小鼠样本上浓度为1:2000 (图 5c). Redox Biol (2019) ncbi
小鼠 单克隆(19/eNOS/S1177)
  • 免疫印迹基因敲除验证; 小鼠; 图 1c
碧迪BD eNOS抗体(BD Transduction, 612393)被用于被用于免疫印迹基因敲除验证在小鼠样本上 (图 1c). Nature (2019) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 小鼠; 图 2b
碧迪BD eNOS抗体(BD, 610296)被用于被用于免疫印迹在小鼠样本上 (图 2b). Sci Transl Med (2017) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 大鼠; 图 1c
碧迪BD eNOS抗体(BD Biosciences, 610296)被用于被用于免疫印迹在大鼠样本上 (图 1c). PLoS ONE (2017) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 大鼠; 1:500; 图 7e
碧迪BD eNOS抗体(BD Transduction Laboratories, 610297)被用于被用于免疫印迹在大鼠样本上浓度为1:500 (图 7e). J Vasc Res (2017) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 人类; 图 1b
碧迪BD eNOS抗体(BD Biosciences, 610296)被用于被用于免疫印迹在人类样本上 (图 1b). J Clin Invest (2016) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 人类; 图 3c
碧迪BD eNOS抗体(BD Transduction Laboratories, 610296)被用于被用于免疫印迹在人类样本上 (图 3c). J Cereb Blood Flow Metab (2017) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 小鼠; 图 2
碧迪BD eNOS抗体(BD Transduction Laboratories, 610297)被用于被用于免疫印迹在小鼠样本上 (图 2). Nat Commun (2016) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 大鼠; 1:500; 图 1B
碧迪BD eNOS抗体(BD, 610297)被用于被用于免疫印迹在大鼠样本上浓度为1:500 (图 1B). Am J Physiol Regul Integr Comp Physiol (2016) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 人类; 图 3d
碧迪BD eNOS抗体(BD Biosciences, 610297)被用于被用于免疫印迹在人类样本上 (图 3d). Sci Rep (2016) ncbi
小鼠 单克隆(19/eNOS/S1177)
  • 免疫印迹; 人类; 图 3b
碧迪BD eNOS抗体(BD Biosciences, 612392)被用于被用于免疫印迹在人类样本上 (图 3b). Ann Thorac Surg (2016) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 人类; 图 2b
碧迪BD eNOS抗体(BD Biosciences, 610296)被用于被用于免疫印迹在人类样本上 (图 2b). Ann Thorac Surg (2016) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫组化-石蜡切片; 小鼠; 1:200; 图 5
碧迪BD eNOS抗体(BD Biosciences, 610296)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:200 (图 5). Theranostics (2016) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 大鼠; 1:2500; 图 3d
碧迪BD eNOS抗体(BD Transduction, 610297)被用于被用于免疫印迹在大鼠样本上浓度为1:2500 (图 3d). Rheumatology (Oxford) (2016) ncbi
小鼠 单克隆(19/eNOS/S1177)
  • 免疫印迹; 大鼠; 1:1000; 图 3c
碧迪BD eNOS抗体(BD Transduction, 612393)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 3c). Rheumatology (Oxford) (2016) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 人类; 1:1000; 图 5b
  • 免疫印迹; 小鼠; 1:1000; 图 6f
碧迪BD eNOS抗体(BD Biosciences, 610297)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5b) 和 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 6f). Oncotarget (2016) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 大鼠; 1:2000; 图 4
碧迪BD eNOS抗体(Becton Dickinson, 610297)被用于被用于免疫印迹在大鼠样本上浓度为1:2000 (图 4). Front Neurosci (2015) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫细胞化学; 人类; 图 3
碧迪BD eNOS抗体(BD Biosciences, 610297)被用于被用于免疫细胞化学在人类样本上 (图 3). Tissue Eng Part C Methods (2016) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫组化-石蜡切片; 大鼠; 1:50; 图 S6
  • 免疫组化; 大鼠; 1:50; 图 2
碧迪BD eNOS抗体(BD transduction laboratories, 610296)被用于被用于免疫组化-石蜡切片在大鼠样本上浓度为1:50 (图 S6) 和 被用于免疫组化在大鼠样本上浓度为1:50 (图 2). Cardiovasc Res (2015) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 人类; 图 3a
碧迪BD eNOS抗体(BD Biosciences, 610297)被用于被用于免疫印迹在人类样本上 (图 3a). J Biol Chem (2015) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 大鼠; 1:500
碧迪BD eNOS抗体(BD Transduction Laboratories, 610297)被用于被用于免疫印迹在大鼠样本上浓度为1:500. Am J Physiol Heart Circ Physiol (2015) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 人类; 1:1000
碧迪BD eNOS抗体(BD BioSciences, 610297)被用于被用于免疫印迹在人类样本上浓度为1:1000. Biol Reprod (2015) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 人类; 图 4
碧迪BD eNOS抗体(BD, 610297)被用于被用于免疫印迹在人类样本上 (图 4). Micron (2015) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 小鼠; 1:5000; 图 5a
碧迪BD eNOS抗体(BD Transduction Laboratories, 610296)被用于被用于免疫印迹在小鼠样本上浓度为1:5000 (图 5a). Biol Open (2015) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫组化-石蜡切片; 小鼠; 1:100; 图 1
碧迪BD eNOS抗体(BD Biosciences, 610297)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:100 (图 1). Am J Physiol Endocrinol Metab (2015) ncbi
小鼠 单克隆(19/eNOS/S1177)
  • 免疫印迹; 小鼠; 1:1000; 图 2
碧迪BD eNOS抗体(BD Transduction Laboratories, 612392)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 2). Am J Physiol Heart Circ Physiol (2015) ncbi
小鼠 单克隆(19/eNOS/S1177)
  • 免疫印迹; 人类; 1:1000; 图 1g
碧迪BD eNOS抗体(BD Transduction Laboratories, 612393)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 1g). Int J Obes (Lond) (2015) ncbi
小鼠 单克隆(31/eNOS)
  • 免疫印迹; 人类; 1:1000; 图 1g
碧迪BD eNOS抗体(BD Transduction Laboratories, 612707)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 1g). Int J Obes (Lond) (2015) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫组化-石蜡切片; domestic rabbit; 1:150
碧迪BD eNOS抗体(BD, 610297)被用于被用于免疫组化-石蜡切片在domestic rabbit样本上浓度为1:150. Clin Exp Pharmacol Physiol (2015) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 小鼠; 1:10,000; 图 5
碧迪BD eNOS抗体(BD Biosciences, 610296)被用于被用于免疫印迹在小鼠样本上浓度为1:10,000 (图 5). J Appl Physiol (1985) (2015) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫细胞化学; 人类
  • 免疫印迹; 人类
碧迪BD eNOS抗体(BD, 610296)被用于被用于免疫细胞化学在人类样本上 和 被用于免疫印迹在人类样本上. Arch Biochem Biophys (2015) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 大鼠; 1:500; 图 3
碧迪BD eNOS抗体(BD Transduction Laboratories, 610297)被用于被用于免疫印迹在大鼠样本上浓度为1:500 (图 3). Am J Physiol Heart Circ Physiol (2014) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫组化; 大鼠; 1:500
碧迪BD eNOS抗体(BD transduction, 610297)被用于被用于免疫组化在大鼠样本上浓度为1:500. Exp Eye Res (2014) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫组化-石蜡切片; domestic rabbit; 1:100
碧迪BD eNOS抗体(BD Bioscience, 610297)被用于被用于免疫组化-石蜡切片在domestic rabbit样本上浓度为1:100. Int J Exp Pathol (2014) ncbi
小鼠 单克隆(19/eNOS/S1177)
  • 免疫印迹; 小鼠; 1:500
碧迪BD eNOS抗体(BD Transduction Laboratories, 612392)被用于被用于免疫印迹在小鼠样本上浓度为1:500. PLoS ONE (2014) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 小鼠; 1:300
碧迪BD eNOS抗体(Transduction Laboratories, 610296)被用于被用于免疫印迹在小鼠样本上浓度为1:300. J Sex Med (2014) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 人类
碧迪BD eNOS抗体(BD Biosciences, 610296)被用于被用于免疫印迹在人类样本上. Cardiovasc Res (2014) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 小鼠; 图 6
碧迪BD eNOS抗体(BD, 610297)被用于被用于免疫印迹在小鼠样本上 (图 6). J Am Heart Assoc (2013) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 人类
碧迪BD eNOS抗体(BD Biosciences, 610296)被用于被用于免疫印迹在人类样本上. J Biol Chem (2013) ncbi
小鼠 单克隆(19/eNOS/S1177)
  • 免疫印迹; 人类
碧迪BD eNOS抗体(BD Biosciences, 612392)被用于被用于免疫印迹在人类样本上. J Biol Chem (2013) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫组化-石蜡切片; 小鼠; 1:100
碧迪BD eNOS抗体(BD Biosciences, 610296)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:100. PLoS ONE (2012) ncbi
小鼠 单克隆(3/eNOS/NOS Type III)
  • 免疫印迹; 人类
碧迪BD eNOS抗体(BD Transduction, 610296)被用于被用于免疫印迹在人类样本上. J Appl Physiol (1985) (2012) ncbi
文章列表
  1. Kuo A, Checa A, Niaudet C, Jung B, Fu Z, Wheelock C, et al. Murine endothelial serine palmitoyltransferase 1 (SPTLC1) is required for vascular development and systemic sphingolipid homeostasis. elife. 2022;11: pubmed 出版商
  2. Chen T, Shi Z, Zhao Y, Meng X, Zhao S, Zheng L, et al. LncRNA Airn maintains LSEC differentiation to alleviate liver fibrosis via the KLF2-eNOS-sGC pathway. BMC Med. 2022;20:335 pubmed 出版商
  3. Hannawi Y, Ewees M, Moore J, Zweier J. Characterizing CD38 Expression and Enzymatic Activity in the Brain of Spontaneously Hypertensive Stroke-Prone Rats. Front Pharmacol. 2022;13:881708 pubmed 出版商
  4. Bartoli F, Debant M, Chuntharpursat Bon E, Evans E, Musialowski K, Parsonage G, et al. Endothelial Piezo1 sustains muscle capillary density and contributes to physical activity. J Clin Invest. 2022;132: pubmed 出版商
  5. Varela López E, del Valle Mondragon L, Castrejón Tellez V, Perez Torres I, Arenas A, Rojas F, et al. Role of the Transient Receptor Potential Vanilloid Type 1 (TRPV1) in the Regulation of Nitric Oxide Release in Wistar Rat Aorta. Oxid Med Cell Longev. 2021;2021:8531975 pubmed 出版商
  6. d Uscio L, Katusic Z. Endothelium-specific deletion of amyloid-β precursor protein exacerbates endothelial dysfunction induced by aging. Aging (Albany NY). 2021;13:19165-19185 pubmed 出版商
  7. Török M, Merkely P, Monori Kiss A, Horvath E, Sziva R, Péterffy B, et al. Network analysis of the left anterior descending coronary arteries in swim-trained rats by an in situ video microscopic technique. Biol Sex Differ. 2021;12:37 pubmed 出版商
  8. Kundumani Sridharan V, Subramani J, Owens C, Das K. Nrg1β Released in Remote Ischemic Preconditioning Improves Myocardial Perfusion and Decreases Ischemia/Reperfusion Injury via ErbB2-Mediated Rescue of Endothelial Nitric Oxide Synthase and Abrogation of Trx2 Autophagy. Arterioscler Thromb Vasc Biol. 2021;41:2293-2314 pubmed 出版商
  9. Tian F, Zhang Y. Overexpression of SERCA2a Alleviates Cardiac Microvascular Ischemic Injury by Suppressing Mfn2-Mediated ER/Mitochondrial Calcium Tethering. Front Cell Dev Biol. 2021;9:636553 pubmed 出版商
  10. Alghanem A, Abello J, Maurer J, Kumar A, Ta C, Gunasekar S, et al. The SWELL1-LRRC8 complex regulates endothelial AKT-eNOS signaling and vascular function. elife. 2021;10: pubmed 出版商
  11. Wanschel A, Guizoni D, Lorza Gil E, Salerno A, Paiva A, Dorighello G, et al. The Presence of Cholesteryl Ester Transfer Protein (CETP) in Endothelial Cells Generates Vascular Oxidative Stress and Endothelial Dysfunction. Biomolecules. 2021;11: pubmed 出版商
  12. Nakayama A, Albarrán Juárez J, Liang G, Roquid K, Iring A, Tonack S, et al. Disturbed flow-induced Gs-mediated signaling protects against endothelial inflammation and atherosclerosis. JCI Insight. 2020;5: pubmed 出版商
  13. Xu B, Chen X, Ding Y, Chen C, Liu T, Zhang H. Abnormal angiogenesis of placenta in progranulin‑deficient mice. Mol Med Rep. 2020;22:3482-3492 pubmed 出版商
  14. Yang C, Eleftheriadou M, Kelaini S, Morrison T, González M, Caines R, et al. Targeting QKI-7 in vivo restores endothelial cell function in diabetes. Nat Commun. 2020;11:3812 pubmed 出版商
  15. MacKay C, Leo M, Fernández Peña C, Hasan R, Yin W, Mata Daboin A, et al. Intravascular flow stimulates PKD2 (polycystin-2) channels in endothelial cells to reduce blood pressure. elife. 2020;9: pubmed 出版商
  16. Schiffner R, Bischoff S, Lehmann T, Irintchev A, Nistor M, Lemke C, et al. Altered Cerebral Blood Flow and Potential Neuroprotective Effect of Human Relaxin-2 (Serelaxin) During Hypoxia or Severe Hypovolemia in a Sheep Model. Int J Mol Sci. 2020;21: pubmed 出版商
  17. Chen Q, Huang M, Wu J, Jiang Q, Zheng X. Exosomes isolated from the plasma of remote ischemic conditioning rats improved cardiac function and angiogenesis after myocardial infarction through targeting Hsp70. Aging (Albany NY). 2020;12:3682-3693 pubmed 出版商
  18. Yang S, Ma C, Wu H, Zhang H, Yuan F, Yang G, et al. Tectorigenin attenuates diabetic nephropathy by improving vascular endothelium dysfunction through activating AdipoR1/2 pathway. Pharmacol Res. 2020;153:104678 pubmed 出版商
  19. Li C, Chen W, Wang J, Xia M, Jia Z, Guo C, et al. Nicotinamide riboside rescues angiotensin II-induced cerebral small vessel disease in mice. CNS Neurosci Ther. 2020;26:438-447 pubmed 出版商
  20. Liu H, Mei F, Yang W, Wang H, Wong E, Cai J, et al. Epac1 inhibition ameliorates pathological angiogenesis through coordinated activation of Notch and suppression of VEGF signaling. Sci Adv. 2020;6:eaay3566 pubmed 出版商
  21. Henning C, Branopolski A, Schuler D, Dimitroulis D, Huelsemann P, Nicolaus C, et al. Requirement of β1 integrin for endothelium-dependent vasodilation and collateral formation in hindlimb ischemia. Sci Rep. 2019;9:16931 pubmed 出版商
  22. Njah K, Chakraborty S, Qiu B, Arumugam S, Raju A, Pobbati A, et al. A Role of Agrin in Maintaining the Stability of Vascular Endothelial Growth Factor Receptor-2 during Tumor Angiogenesis. Cell Rep. 2019;28:949-965.e7 pubmed 出版商
  23. Guan J, Lin H, Xie M, Huang M, Zhang D, Ma S, et al. Higenamine exerts an antispasmodic effect on cold-induced vasoconstriction by regulating the PI3K/Akt, ROS/α2C-AR and PTK9 pathways independently of the AMPK/eNOS/NO axis. Exp Ther Med. 2019;18:1299-1308 pubmed 出版商
  24. Iring A, Jin Y, Albarrán Juárez J, Siragusa M, Wang S, Dancs P, et al. Shear stress-induced endothelial adrenomedullin signaling regulates vascular tone and blood pressure. J Clin Invest. 2019;129:2775-2791 pubmed 出版商
  25. Fei J, Sun Y, Duan Y, Xia J, Yu S, Ouyang P, et al. Low concentration of rutin treatment might alleviate the cardiotoxicity effect of pirarubicin on cardiomyocytes via activation of PI3K/AKT/mTOR signaling pathway. Biosci Rep. 2019;: pubmed 出版商
  26. Coulombe P, Paliouras G, Clayton A, Hussainkhel A, Fuller M, Jovanovic V, et al. Endothelial Sash1 Is Required for Lung Maturation through Nitric Oxide Signaling. Cell Rep. 2019;27:1769-1780.e4 pubmed 出版商
  27. Schiattarella G, Altamirano F, Tong D, French K, Villalobos E, Kim S, et al. Nitrosative stress drives heart failure with preserved ejection fraction. Nature. 2019;568:351-356 pubmed 出版商
  28. Li Q, Youn J, Siu K, Murugesan P, Zhang Y, Cai H. Knockout of dihydrofolate reductase in mice induces hypertension and abdominal aortic aneurysm via mitochondrial dysfunction. Redox Biol. 2019;24:101185 pubmed 出版商
  29. Shao J, Miao C, Geng Z, Gu M, Wu Y, Li Q. Effect of eNOS on Ischemic Postconditioning-Induced Autophagy against Ischemia/Reperfusion Injury in Mice. Biomed Res Int. 2019;2019:5201014 pubmed 出版商
  30. Chen Q, Xiang J, Gong R, Fang H, Xu C, Zhang H, et al. Atorvastatin downregulates HSP22 expression in an atherosclerotic model in vitro and in vivo. Int J Mol Med. 2019;43:821-829 pubmed 出版商
  31. Zhou H, Zhang R, Anand P, Stomberski C, Qian Z, Hausladen A, et al. Metabolic reprogramming by the S-nitroso-CoA reductase system protects against kidney injury. Nature. 2019;565:96-100 pubmed 出版商
  32. Zhan R, Wang F, Wu Y, Wang Y, Qian W, Liu M, et al. Nitric oxide induces epidermal stem cell de-adhesion by targeting integrin β1 and Talin via the cGMP signalling pathway. Nitric Oxide. 2018;78:1-10 pubmed 出版商
  33. Das A, Huang G, Bonkowski M, Longchamp A, Li C, Schultz M, et al. Impairment of an Endothelial NAD+-H2S Signaling Network Is a Reversible Cause of Vascular Aging. Cell. 2018;173:74-89.e20 pubmed 出版商
  34. Hwangbo C, Wu J, Papangeli I, Adachi T, Sharma B, Park S, et al. Endothelial APLNR regulates tissue fatty acid uptake and is essential for apelin's glucose-lowering effects. Sci Transl Med. 2017;9: pubmed 出版商
  35. Kim J, Kim Y, Kim J, Park D, Bae H, Lee D, et al. YAP/TAZ regulates sprouting angiogenesis and vascular barrier maturation. J Clin Invest. 2017;127:3441-3461 pubmed 出版商
  36. Azimzadeh O, Subramanian V, Ständer S, Merl Pham J, Lowe D, Barjaktarovic Z, et al. Proteome analysis of irradiated endothelial cells reveals persistent alteration in protein degradation and the RhoGDI and NO signalling pathways. Int J Radiat Biol. 2017;93:920-928 pubmed 出版商
  37. Gupta A, Anjomani Virmouni S, Koundouros N, Dimitriadi M, Choo Wing R, Valle A, et al. PARK2 Depletion Connects Energy and Oxidative Stress to PI3K/Akt Activation via PTEN S-Nitrosylation. Mol Cell. 2017;65:999-1013.e7 pubmed 出版商
  38. Yang G, Zhao Z, Qin T, Wang D, Chen L, Xiang R, et al. TNFSF15 inhibits VEGF-stimulated vascular hyperpermeability by inducing VEGFR2 dephosphorylation. FASEB J. 2017;31:2001-2012 pubmed 出版商
  39. Himori K, Abe M, Tatebayashi D, Lee J, Westerblad H, Lanner J, et al. Superoxide dismutase/catalase mimetic EUK-134 prevents diaphragm muscle weakness in monocrotalin-induced pulmonary hypertension. PLoS ONE. 2017;12:e0169146 pubmed 出版商
  40. Merdzo I, Rutkai I, Sure V, McNulty C, Katakam P, Busija D. Impaired Mitochondrial Respiration in Large Cerebral Arteries of Rats with Type 2 Diabetes. J Vasc Res. 2017;54:1-12 pubmed 出版商
  41. Wang Q, Wu S, Zhu H, Ding Y, Dai X, Ouyang C, et al. Deletion of PRKAA triggers mitochondrial fission by inhibiting the autophagy-dependent degradation of DNM1L. Autophagy. 2017;13:404-422 pubmed 出版商
  42. Tancharoen W, Aungsuchawan S, Pothacharoen P, Markmee R, Narakornsak S, Kieodee J, et al. Differentiation of mesenchymal stem cells from human amniotic fluid to vascular endothelial cells. Acta Histochem. 2017;119:113-121 pubmed 出版商
  43. Lee S, Rho S, Park H, Park J, Kim J, Lee I, et al. Carbohydrate-binding protein CLEC14A regulates VEGFR-2- and VEGFR-3-dependent signals during angiogenesis and lymphangiogenesis. J Clin Invest. 2017;127:457-471 pubmed 出版商
  44. Stratmann B, Engelbrecht B, Espelage B, Klusmeier N, Tiemann J, Gawlowski T, et al. Glyoxalase 1-knockdown in human aortic endothelial cells - effect on the proteome and endothelial function estimates. Sci Rep. 2016;6:37737 pubmed 出版商
  45. Wang S, Chennupati R, Kaur H, Iring A, Wettschureck N, Offermanns S. Endothelial cation channel PIEZO1 controls blood pressure by mediating flow-induced ATP release. J Clin Invest. 2016;126:4527-4536 pubmed 出版商
  46. Mahmoud A, Szczurek M, Blackburn B, Mey J, Chen Z, Robinson A, et al. Hyperinsulinemia augments endothelin-1 protein expression and impairs vasodilation of human skeletal muscle arterioles. Physiol Rep. 2016;4: pubmed
  47. Song C, Liu B, Shi Y, Liu N, Yan Y, Zhang J, et al. MicroRNA-130a alleviates human coronary artery endothelial cell injury and inflammatory responses by targeting PTEN via activating PI3K/Akt/eNOS signaling pathway. Oncotarget. 2016;7:71922-71936 pubmed 出版商
  48. Egholm C, Khammy M, Dalsgaard T, Mazur A, Tritsaris K, Hansen A, et al. GLP-1 inhibits VEGFA-mediated signaling in isolated human endothelial cells and VEGFA-induced dilation of rat mesenteric arteries. Am J Physiol Heart Circ Physiol. 2016;311:H1214-H1224 pubmed 出版商
  49. Gross S, Devraj K, Feng Y, Macas J, Liebner S, Wieland T. Nucleoside diphosphate kinase B regulates angiogenic responses in the endothelium via caveolae formation and c-Src-mediated caveolin-1 phosphorylation. J Cereb Blood Flow Metab. 2017;37:2471-2484 pubmed 出版商
  50. Vikram A, Kim Y, Kumar S, Li Q, Kassan M, JACOBS J, et al. Vascular microRNA-204 is remotely governed by the microbiome and impairs endothelium-dependent vasorelaxation by downregulating Sirtuin1. Nat Commun. 2016;7:12565 pubmed 出版商
  51. Lee M, Tsai K, Hsu J, Shin S, Wu J, Yeh J. Liraglutide prevents and reverses monocrotaline-induced pulmonary arterial hypertension by suppressing ET-1 and enhancing eNOS/sGC/PKG pathways. Sci Rep. 2016;6:31788 pubmed 出版商
  52. Spradley F, Sasser J, Musall J, Sullivan J, Granger J. Nitric oxide synthase-mediated blood pressure regulation in obese melanocortin-4 receptor-deficient pregnant rats. Am J Physiol Regul Integr Comp Physiol. 2016;311:R851-R857 pubmed 出版商
  53. Hammers D, Sleeper M, Forbes S, Shima A, Walter G, Sweeney H. Tadalafil Treatment Delays the Onset of Cardiomyopathy in Dystrophin-Deficient Hearts. J Am Heart Assoc. 2016;5: pubmed 出版商
  54. Kojima Y, Volkmer J, McKenna K, Civelek M, Lusis A, Miller C, et al. CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis. Nature. 2016;536:86-90 pubmed
  55. Yu Q, Song W, Wang D, Zeng Y. Identification of blood vascular endothelial stem cells by the expression of protein C receptor. Cell Res. 2016;26:1079-1098 pubmed 出版商
  56. Tsai S, Huang P, Hsu Y, Peng Y, Lee C, Wang J, et al. Inhibition of hypoxia inducible factor-1α attenuates abdominal aortic aneurysm progression through the down-regulation of matrix metalloproteinases. Sci Rep. 2016;6:28612 pubmed 出版商
  57. Legeay S, Clere N, Hilairet G, Do Q, Bernard P, Quignard J, et al. The insect repellent N,N-diethyl-m-toluamide (DEET) induces angiogenesis via allosteric modulation of the M3 muscarinic receptor in endothelial cells. Sci Rep. 2016;6:28546 pubmed 出版商
  58. Burger D, Turner M, Munkonda M, Touyz R. Endothelial Microparticle-Derived Reactive Oxygen Species: Role in Endothelial Signaling and Vascular Function. Oxid Med Cell Longev. 2016;2016:5047954 pubmed 出版商
  59. Kotlarczyk M, Billaud M, Green B, Hill J, Shiva S, Kelley E, et al. Regional Disruptions in Endothelial Nitric Oxide Pathway Associated With Bicuspid Aortic Valve. Ann Thorac Surg. 2016;102:1274-81 pubmed 出版商
  60. Huang R, Harmsen S, Samii J, Karabeber H, Pitter K, Holland E, et al. High Precision Imaging of Microscopic Spread of Glioblastoma with a Targeted Ultrasensitive SERRS Molecular Imaging Probe. Theranostics. 2016;6:1075-84 pubmed 出版商
  61. Burke S, Zsengellér Z, Khankin E, Lo A, Rajakumar A, Dupont J, et al. Soluble fms-like tyrosine kinase 1 promotes angiotensin II sensitivity in preeclampsia. J Clin Invest. 2016;126:2561-74 pubmed 出版商
  62. Eirin A, Ebrahimi B, Kwon S, Fiala J, Williams B, Woollard J, et al. Restoration of Mitochondrial Cardiolipin Attenuates Cardiac Damage in Swine Renovascular Hypertension. J Am Heart Assoc. 2016;5: pubmed 出版商
  63. Totoson P, Maguin Gaté K, Prigent Tessier A, Monnier A, Verhoeven F, Marie C, et al. Etanercept improves endothelial function via pleiotropic effects in rat adjuvant-induced arthritis. Rheumatology (Oxford). 2016;55:1308-17 pubmed 出版商
  64. Tran Q, Firkins R, Giles J, Francis S, Matnishian V, Tran P, et al. Estrogen Enhances Linkage in the Vascular Endothelial Calmodulin Network via a Feedforward Mechanism at the G Protein-coupled Estrogen Receptor 1. J Biol Chem. 2016;291:10805-23 pubmed 出版商
  65. Takır S, Gürel Gürevin E, Toprak A, Demirci Tansel C, UydeÅŸ DoÄŸan B. The elevation of intraocular pressure is associated with apoptosis and increased immunoreactivity for nitric oxide synthase in rat retina whereas the effectiveness of retina derived relaxing factor is unaffected. Exp Eye Res. 2016;145:401-411 pubmed 出版商
  66. Sönmez M, Dündar M. Ameliorative effects of pentoxifylline on NOS induced by diabetes in rat kidney. Ren Fail. 2016;38:605-13 pubmed 出版商
  67. Alonso F, Domingos Pereira S, Le Gal L, Derré L, Meda P, Jichlinski P, et al. Targeting endothelial connexin40 inhibits tumor growth by reducing angiogenesis and improving vessel perfusion. Oncotarget. 2016;7:14015-28 pubmed 出版商
  68. Kim J, He X, Orr B, Wutz G, Hill V, Peters J, et al. Intact Cohesion, Anaphase, and Chromosome Segregation in Human Cells Harboring Tumor-Derived Mutations in STAG2. PLoS Genet. 2016;12:e1005865 pubmed 出版商
  69. Lee S, Kang B, Shin M, Min J, Heo C, Lee Y, et al. Chronic Stress Decreases Cerebrovascular Responses During Rat Hindlimb Electrical Stimulation. Front Neurosci. 2015;9:462 pubmed 出版商
  70. Baptista P, Moran E, Vyas D, Ribeiro M, Atala A, Sparks J, et al. Fluid Flow Regulation of Revascularization and Cellular Organization in a Bioengineered Liver Platform. Tissue Eng Part C Methods. 2016;22:199-207 pubmed 出版商
  71. Ge W, Yuan M, Ceylan A, Wang X, Ren J. Mitochondrial aldehyde dehydrogenase protects against doxorubicin cardiotoxicity through a transient receptor potential channel vanilloid 1-mediated mechanism. Biochim Biophys Acta. 2016;1862:622-634 pubmed 出版商
  72. Sönmez M, Kılıç E, Karabulut D, Çilenk K, Deligönül E, Dündar M. Nitric oxide synthase in diabetic rat testicular tissue and the effects of pentoxifylline therapy. Syst Biol Reprod Med. 2016;62:22-30 pubmed 出版商
  73. Pellet Many C, Mehta V, Fields L, Mahmoud M, Lowe V, Evans I, et al. Neuropilins 1 and 2 mediate neointimal hyperplasia and re-endothelialization following arterial injury. Cardiovasc Res. 2015;108:288-98 pubmed 出版商
  74. Sasaki N, Itakura Y, Toyoda M. Ganglioside GM1 Contributes to the State of Insulin Resistance in Senescent Human Arterial Endothelial Cells. J Biol Chem. 2015;290:25475-86 pubmed 出版商
  75. Rutkai I, Dutta S, Katakam P, Busija D. Dynamics of enhanced mitochondrial respiration in female compared with male rat cerebral arteries. Am J Physiol Heart Circ Physiol. 2015;309:H1490-500 pubmed 出版商
  76. Anaya H, Yi F, Boeldt D, Krupp J, Grummer M, Shah D, et al. Changes in Ca2+ Signaling and Nitric Oxide Output by Human Umbilical Vein Endothelium in Diabetic and Gestational Diabetic Pregnancies. Biol Reprod. 2015;93:60 pubmed 出版商
  77. Johlfs M, Gorjala P, Urasaki Y, Le T, Fiscus R. Capillary Isoelectric Focusing Immunoassay for Fat Cell Differentiation Proteomics. PLoS ONE. 2015;10:e0132105 pubmed 出版商
  78. Yokomori H, Ando W, Yoshimura K, Yamazaki H, Takahashi Y, Oda M. Increases in endothelial caveolin-1 and cavins correlate with cirrhosis progression. Micron. 2015;76:52-61 pubmed 出版商
  79. Nasrallah R, Knezevic K, Thai T, Thomas S, Göttgens B, Lacaud G, et al. Endoglin potentiates nitric oxide synthesis to enhance definitive hematopoiesis. Biol Open. 2015;4:819-29 pubmed 出版商
  80. Yamaleyeva L, Pulgar V, Lindsey S, Yamane L, Varagic J, McGee C, et al. Uterine artery dysfunction in pregnant ACE2 knockout mice is associated with placental hypoxia and reduced umbilical blood flow velocity. Am J Physiol Endocrinol Metab. 2015;309:E84-94 pubmed 出版商
  81. Ng H, Jelinic M, Parry L, Leo C. Increased superoxide production and altered nitric oxide-mediated relaxation in the aorta of young but not old male relaxin-deficient mice. Am J Physiol Heart Circ Physiol. 2015;309:H285-96 pubmed 出版商
  82. Pardo F, Silva L, Sáez T, Salsoso R, Gutiérrez J, Sanhueza C, et al. Human supraphysiological gestational weight gain and fetoplacental vascular dysfunction. Int J Obes (Lond). 2015;39:1264-73 pubmed 出版商
  83. Smith R, Klein R, Kruzliak P, Zulli A. Role of Peptide YY in blood vessel function and atherosclerosis in a rabbit model. Clin Exp Pharmacol Physiol. 2015;42:648-52 pubmed 出版商
  84. Liu Z, Jiang C, Zhang J, Liu B, Du Q. Resveratrol inhibits inflammation and ameliorates insulin resistant endothelial dysfunction via regulation of AMP-activated protein kinase and sirtuin 1 activities. J Diabetes. 2016;8:324-35 pubmed 出版商
  85. Hong Y, Frugier T, Zhang X, Murphy R, Lynch G, Betik A, et al. Glucose uptake during contraction in isolated skeletal muscles from neuronal nitric oxide synthase μ knockout mice. J Appl Physiol (1985). 2015;118:1113-21 pubmed 出版商
  86. Golob M, Tian L, Wang Z, Zimmerman T, Caneba C, Hacker T, et al. Mitochondria DNA mutations cause sex-dependent development of hypertension and alterations in cardiovascular function. J Biomech. 2015;48:405-12 pubmed 出版商
  87. Chang K, Nayak R, Roy S, Perumbeti A, Wellendorf A, Bezold K, et al. Vasculopathy-associated hyperangiotensinemia mobilizes haematopoietic stem cells/progenitors through endothelial ATâ‚‚R and cytoskeletal dysregulation. Nat Commun. 2015;6:5914 pubmed 出版商
  88. Hu J, Ma S, Zou S, Li X, Cui P, WeijdegÃ¥rd B, et al. The regulation of nitric oxide synthase isoform expression in mouse and human fallopian tubes: potential insights for ectopic pregnancy. Int J Mol Sci. 2014;16:49-67 pubmed 出版商
  89. Tang Y, Yin Y, Miao L, Wei B, Zhai K, Ji G. Nitric oxide enhances extracellular ATP induced Ca²⁺ oscillation in HeLa cells. Arch Biochem Biophys. 2015;565:68-75 pubmed 出版商
  90. Ansari M, Roberts K, Scheff S. A time course of NADPH-oxidase up-regulation and endothelial nitric oxide synthase activation in the hippocampus following neurotrauma. Free Radic Biol Med. 2014;77:21-9 pubmed 出版商
  91. Rutkai I, Katakam P, Dutta S, Busija D. Sustained mitochondrial functioning in cerebral arteries after transient ischemic stress in the rat: a potential target for therapies. Am J Physiol Heart Circ Physiol. 2014;307:H958-66 pubmed 出版商
  92. Shibeeb O, Wood J, Casson R, Chidlow G. Effects of a conventional photocoagulator and a 3-ns pulse laser on preconditioning responses and retinal ganglion cell survival after optic nerve crush. Exp Eye Res. 2014;127:77-90 pubmed 出版商
  93. Habiyakare B, Alsaadon H, Mathai M, Hayes A, Zulli A. Reduction of angiotensin A and alamandine vasoactivity in the rabbit model of atherogenesis: differential effects of alamandine and Ang(1-7). Int J Exp Pathol. 2014;95:290-5 pubmed 出版商
  94. Tobin G, Zhang J, Goodwin D, Stewart S, Xu L, Knapton A, et al. The role of eNOS phosphorylation in causing drug-induced vascular injury. Toxicol Pathol. 2014;42:709-24 pubmed 出版商
  95. Swärd K, Albinsson S, Rippe C. Arterial dysfunction but maintained systemic blood pressure in cavin-1-deficient mice. PLoS ONE. 2014;9:e92428 pubmed 出版商
  96. Tavukçu H, Sener T, Tinay I, Akbal C, Ersahin M, Cevik O, et al. Melatonin and tadalafil treatment improves erectile dysfunction after spinal cord injury in rats. Clin Exp Pharmacol Physiol. 2014;41:309-16 pubmed 出版商
  97. Shao D, Zhai P, Del Re D, Sciarretta S, Yabuta N, Nojima H, et al. A functional interaction between Hippo-YAP signalling and FoxO1 mediates the oxidative stress response. Nat Commun. 2014;5:3315 pubmed 出版商
  98. Song K, Chung J, Choi M, Jin H, Yin G, Kwon M, et al. Effectiveness of intracavernous delivery of adenovirus encoding Smad7 gene on erectile function in a mouse model of cavernous nerve injury. J Sex Med. 2014;11:51-63 pubmed 出版商
  99. Fessner A, Esser J, Bluhm F, Grundmann S, Zhou Q, Patterson C, et al. The transcription factor HoxB5 stimulates vascular remodelling in a cytokine-dependent manner. Cardiovasc Res. 2014;101:247-55 pubmed 出版商
  100. Xiong Y, Yu Y, Montani J, Yang Z, Ming X. Arginase-II induces vascular smooth muscle cell senescence and apoptosis through p66Shc and p53 independently of its l-arginine ureahydrolase activity: implications for atherosclerotic plaque vulnerability. J Am Heart Assoc. 2013;2:e000096 pubmed 出版商
  101. Hou Z, Nie C, Si Z, Ma Y. Deferoxamine enhances neovascularization and accelerates wound healing in diabetic rats via the accumulation of hypoxia-inducible factor-1?. Diabetes Res Clin Pract. 2013;101:62-71 pubmed 出版商
  102. Zhu X, Li P, Yang Y, Liu M. Xuezhikang, extract of red yeast rice, improved abnormal hemorheology, suppressed caveolin-1 and increased eNOS expression in atherosclerotic rats. PLoS ONE. 2013;8:e62731 pubmed 出版商
  103. Haeussler D, Pimentel D, Hou X, Burgoyne J, Cohen R, Bachschmid M. Endomembrane H-Ras controls vascular endothelial growth factor-induced nitric-oxide synthase-mediated endothelial cell migration. J Biol Chem. 2013;288:15380-9 pubmed 出版商
  104. Helmy K, Halliday J, Fomchenko E, Setty M, Pitter K, Hafemeister C, et al. Identification of global alteration of translational regulation in glioma in vivo. PLoS ONE. 2012;7:e46965 pubmed 出版商
  105. Ives S, Andtbacka R, Kwon S, Shiu Y, Ruan T, Noyes R, et al. Heat and ?1-adrenergic responsiveness in human skeletal muscle feed arteries: the role of nitric oxide. J Appl Physiol (1985). 2012;113:1690-8 pubmed 出版商